Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Neurosurgical Clinic, Duesseldorf, Germany
National Taiwan University Hospital, Taipei, Taiwan
Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou, Guangdong, China
Ajou University hospital, Suwon, Korea, Republic of
Unit for Human Reproduction, 1st Dept of OB/Gyn, Medical School, Aristotle UNiversity of Thessaloniki, Thessaloniki, Greece
Far Eastern Memorial Hospital, New Taipei City, Taiwan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.